ArticleCancer biology & therapy2018

Integration of genomics, high throughput drug screening, and personalized xenograft models as a novel precision medicine paradigm for high risk pediatric cancer.

Maria Tsoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.